Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder

@article{Austin1991DopamineBA,
  title={Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder},
  author={L. Austin and R. Lydiard and J. Ballenger and B. Cohen and E. Ellinwood},
  journal={Biological Psychiatry},
  year={1991},
  volume={30},
  pages={225-232}
}
  • L. Austin, R. Lydiard, +2 authors E. Ellinwood
  • Published 1991
  • Psychology, Medicine
  • Biological Psychiatry
  • While many data suggest that Obsessive-Compulsive Disorder (OCD) is an illness accompanied by dysregulation of the serotonergic system, interesting clinical evidence and animal studies also suggest possible dysregulation of the dopaminergic (DA) system. In order to determine whether clomipramine (CMI), an antiobsessional agent, is capable of altering DA function, we performed a neuroleptic radioreceptor assay (NRRA) on plasma samples from OCD patients before and after treatment in a double… CONTINUE READING
    47 Citations
    Growth hormone response to apomorphine in obsessive-compulsive disorder.
    • 16
    THE PATHOPHYSIOLOGY AND GENETICS OF OBSESSIVE-COMPULSIVE DISORDER
    • 5
    • PDF
    Obsessive-Compulsive Disorder in Elderly Patients
    • 5
    Pharmacological Treatment of Childhood Obsessive-Compulsive Disorder: From Theory to Practice
    • 34
    Intravenous clomipramine in severe and refractory obsessive-compulsive disorder.
    • 4
    Management of schizophrenia with obsessive-compulsive features.
    • 43
    An update on the pharmacological treatment of obsessive-compulsive disorder
    • 40

    References

    SHOWING 1-10 OF 31 REFERENCES
    Obsessive-compulsive disorder and serotonin: Is there a connection?
    • 313
    Clomipramine in obsessive-compulsive disorder
    • 83